Is Pirfenidone a Specialty Drug? An Examination of Its Classification
•
4 min read
In 2014, the FDA granted approval to pirfenidone, marking it as a significant treatment for idiopathic pulmonary fibrosis (IPF). As a result, many patients and healthcare providers question the medication's specific classification, with the answer being that pirfenidone is definitively considered a specialty drug due to its cost, complexity, and distribution model.
